Skip to Content
Paid Content

Takeda’s CEO on taking the Fortune Global 500 company into the future

Christophe Weber has transformed the centuries-old Japanese biopharmaceuticals company by prioritizing innovation and globalization.

For more than 200 years, Takeda has focused on creating potentially life-changing treatments for patients. Since 2014, president & CEO Christophe Weber has led the company’s values-based and R&D-driven approach, which has not only helped it grow into one of the largest pharmaceutical companies in the world, but also to deliver highly innovative medicines to more people worldwide. Now, Weber’s investment in innovation and patient care has landed the biopharmaceutical leader on the Fortune Global 500 for the second consecutive year.

In the video above, Fortune CEO Alan Murray speaks with Weber about how his vision has helped transform the company—and what’s in store for the future.